If you have corrections, questions, or feedback about the site's coverage of ibogaine for fighters, we welcome brief messages and will update the resource as needed. For clarity on editorial standards and sourcing, see our overview.
You can reach the site through its published channels; check back for a direct contact address and subscribe-free notices. For more about how information is selected and reviewed, read the section on our editorial approach at our About page, which explains sourcing and scope.
This resource links to domain-specific materials such as the overview at ibogainemma background and notes and comparative pages like ibogaine versus mushrooms analysis to illustrate coverage differences relevant to fighters.
Readers who wish to review clinical-focused summaries referenced by our editors may consult specialist sites such as ibogaine and depression materials and evaluation pages like does ibogaine treatment work for additional context.
Information about availability in nearby regions is sometimes linked via directories such as Mexico ibogaine treatment resources when location-specific details are relevant to a fighter's planning.
Currently, MMA Ibogaine does not publish a direct contact email. The site can be reached through its published channels and updates; please check this page for future posting of a verified contact method. For questions about the site's aims and editorial rules, see the summary available on the site homepage which outlines primary topics and audience focus.
MMA Ibogaine is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice. The site is focused on serving MMA and combat-sport fighters with audience-specific evidence and does not make treatment offers or clinical claims.
Editors sometimes reference external explanatory pages when noting differences in approach; for example, comparative write-ups such as those at ibogainemma background and notes inform editorial context.